Suppr超能文献

配体发现:高通量结合:荧光偏振(各向异性)。

Ligand Discovery: High-Throughput Binding: Fluorescence Polarization (Anisotropy).

机构信息

Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca, Alderley Park, UK.

AstraZeneca R&D Discovery Sciences, Cambridge, UK.

出版信息

Methods Mol Biol. 2021;2263:231-246. doi: 10.1007/978-1-0716-1197-5_10.

Abstract

High-throughput assays based on fluorescence polarization (or fluorescence anisotropy) technology have often been employed for primary hit-finding in drug discovery. These binding assays provide a homogeneous format and consistent performance and offer advantages over some other optical methods. Developments in assay design and improvements in fluorescent probes have enabled the application of the technique to even complex biological systems. Here we describe the practical considerations for development of FP assays applied in high-throughput screening, including fluorophore selection, assay design, data analysis, and approaches for detecting compound interference.

摘要

基于荧光偏振(或荧光各向异性)技术的高通量检测方法常用于药物发现中的初步命中筛选。这些结合检测方法提供了均相格式和一致的性能,并优于其他一些光学方法。检测设计的发展和荧光探针的改进使该技术甚至能够应用于复杂的生物系统。在这里,我们将描述应用于高通量筛选的 FP 检测方法的开发的实际考虑因素,包括荧光团的选择、检测设计、数据分析以及检测化合物干扰的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验